Aldeyra Therapeutics's total assets for Q1 2025 were $93.20T, an increase of 89091442.27% from the previous quarter. ALDX total liabilities were $29.60T for the fiscal quarter, a 88081847.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.